vs
Side-by-side financial comparison of Laser Photonics Corp (LASE) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
PLUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($1.4M vs $919.3K, roughly 1.5× Laser Photonics Corp). PLUS THERAPEUTICS, INC. runs the higher net margin — -417.9% vs -506.4%, a 88.5% gap on every dollar of revenue. On growth, Laser Photonics Corp posted the faster year-over-year revenue change (28.3% vs -3.2%). Over the past eight quarters, Laser Photonics Corp's revenue compounded faster (-3.9% CAGR vs -9.7%).
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
LASE vs PSTV — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $919.3K | $1.4M |
| Net Profit | $-4.7M | $-5.7M |
| Gross Margin | -20.1% | — |
| Operating Margin | -350.0% | -420.0% |
| Net Margin | -506.4% | -417.9% |
| Revenue YoY | 28.3% | -3.2% |
| Net Profit YoY | -186.5% | -46.4% |
| EPS (diluted) | $-0.27 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.4M | ||
| Q3 25 | $919.3K | $1.4M | ||
| Q2 25 | $2.6M | $1.4M | ||
| Q1 25 | $2.3M | $1.1M | ||
| Q4 24 | $1.3M | $1.4M | ||
| Q3 24 | $716.7K | $1.5M | ||
| Q2 24 | $623.4K | $1.3M | ||
| Q1 24 | $743.0K | $1.7M |
| Q4 25 | — | $-5.7M | ||
| Q3 25 | $-4.7M | $-4.4M | ||
| Q2 25 | $-1.8M | $5.2M | ||
| Q1 25 | $-1.7M | $-17.4M | ||
| Q4 24 | $586.4K | $-3.9M | ||
| Q3 24 | $-1.6M | $-2.9M | ||
| Q2 24 | $-934.3K | $-2.9M | ||
| Q1 24 | $-545.7K | $-3.3M |
| Q4 25 | — | — | ||
| Q3 25 | -20.1% | — | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | 49.8% | — | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | 85.0% | — | ||
| Q2 24 | 50.6% | — | ||
| Q1 24 | 51.9% | — |
| Q4 25 | — | -420.0% | ||
| Q3 25 | -350.0% | -320.8% | ||
| Q2 25 | -37.0% | -110.6% | ||
| Q1 25 | -68.7% | -333.9% | ||
| Q4 24 | -255.1% | -276.2% | ||
| Q3 24 | -238.0% | -260.9% | ||
| Q2 24 | -149.4% | -289.1% | ||
| Q1 24 | -73.8% | -196.7% |
| Q4 25 | — | -417.9% | ||
| Q3 25 | -506.4% | -316.6% | ||
| Q2 25 | -68.3% | 370.6% | ||
| Q1 25 | -73.4% | -1643.2% | ||
| Q4 24 | 45.7% | -276.4% | ||
| Q3 24 | -226.8% | -197.4% | ||
| Q2 24 | -149.9% | -229.9% | ||
| Q1 24 | -73.4% | -194.5% |
| Q4 25 | — | $0.95 | ||
| Q3 25 | $-0.27 | $-0.04 | ||
| Q2 25 | $-0.12 | $-0.01 | ||
| Q1 25 | $-0.12 | $-1.19 | ||
| Q4 24 | $0.06 | $-0.51 | ||
| Q3 24 | $-0.13 | $-0.37 | ||
| Q2 24 | $-0.09 | $-0.71 | ||
| Q1 24 | $-0.06 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.1M | $4.0M |
| Total Assets | $17.5M | $16.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | $3.6M | $16.6M | ||
| Q2 25 | $78.5K | $6.9M | ||
| Q1 25 | $179.1K | $9.9M | ||
| Q4 24 | $533.9K | $3.6M | ||
| Q3 24 | $2.1M | $4.8M | ||
| Q2 24 | $2.7M | $8.4M | ||
| Q1 24 | $5.2M | $3.2M |
| Q4 25 | — | $4.0M | ||
| Q3 25 | $4.1M | $5.1M | ||
| Q2 25 | $4.3M | $3.0M | ||
| Q1 25 | $6.8M | $-23.6M | ||
| Q4 24 | $10.2M | $-8.9M | ||
| Q3 24 | $9.7M | $-5.2M | ||
| Q2 24 | $10.3M | $-7.6M | ||
| Q1 24 | $12.4M | $-4.8M |
| Q4 25 | — | $16.3M | ||
| Q3 25 | $17.5M | $18.7M | ||
| Q2 25 | $14.9M | $10.3M | ||
| Q1 25 | $16.0M | $12.1M | ||
| Q4 24 | $17.2M | $6.6M | ||
| Q3 24 | $10.6M | $7.0M | ||
| Q2 24 | $11.1M | $11.2M | ||
| Q1 24 | $13.6M | $5.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $763.1K | $-6.3M |
| Free Cash FlowOCF − Capex | — | $-6.3M |
| FCF MarginFCF / Revenue | — | -459.9% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-6.3M | ||
| Q3 25 | $763.1K | $-2.5M | ||
| Q2 25 | $-1.0M | $-5.8M | ||
| Q1 25 | $-1.2M | $-6.2M | ||
| Q4 24 | $-6.5M | $-1.2M | ||
| Q3 24 | $632.7K | $-3.7M | ||
| Q2 24 | $-2.4M | $-1.1M | ||
| Q1 24 | $-866.3K | $-4.5M |
| Q4 25 | — | $-6.3M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $-5.8M | ||
| Q1 25 | — | $-6.2M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | $589.6K | $-3.7M | ||
| Q2 24 | $-2.4M | $-1.2M | ||
| Q1 24 | $-1.0M | $-4.6M |
| Q4 25 | — | -459.9% | ||
| Q3 25 | — | -184.3% | ||
| Q2 25 | — | -417.6% | ||
| Q1 25 | — | -583.1% | ||
| Q4 24 | — | -86.5% | ||
| Q3 24 | 82.3% | -253.7% | ||
| Q2 24 | -388.0% | -96.2% | ||
| Q1 24 | -136.9% | -271.5% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | 6.0% | 1.0% | ||
| Q2 24 | 5.1% | 6.3% | ||
| Q1 24 | 20.3% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.13× | ||
| Q1 25 | — | — | ||
| Q4 24 | -11.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
